Sale!

POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation Type B2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POMT2 gene muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) genetic test is a specialized diagnostic assessment available at DNA Labs UAE. This test is designed to identify mutations in the POMT2 gene, which are known to cause a rare form of muscular dystrophy characterized by congenital muscle weakness, structural brain anomalies, and intellectual disabilities. The condition is part of a group of disorders known as dystroglycanopathies, which affect the dystroglycan protein complex—a key component in muscle cell stability and brain development.

The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of genetic abnormalities in the POMT2 gene. This genetic testing is crucial for early diagnosis and management of the condition, allowing for targeted interventions and support to improve the quality of life for affected individuals and their families. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes, providing essential genetic insights for patients dealing with this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation Type B2 Genetic Test

Test Name: POMT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation Type B2 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Mental Retardation), Type B2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Mental Retardation), Type B2.

Test Details: The POMT2 gene is associated with a specific type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2. This genetic disorder is characterized by muscle weakness and wasting, intellectual disability, and structural abnormalities in the brain. NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of POMT2 gene-related disorders, NGS genetic testing can identify any variations or mutations in the POMT2 gene that may be causing the disease. NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment planning. It can help confirm the presence of specific genetic mutations, guide appropriate medical management, and provide genetic counseling to affected individuals and their families. It’s important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations.

Test Name POMT2 Gene Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMT2 Gene Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2
Test Details

The POMT2 gene is associated with a specific type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2. This genetic disorder is characterized by muscle weakness and wasting, intellectual disability, and structural abnormalities in the brain.

NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of POMT2 gene-related disorders, NGS genetic testing can identify any variations or mutations in the POMT2 gene that may be causing the disease.

NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment planning. It can help confirm the presence of specific genetic mutations, guide appropriate medical management, and provide genetic counseling to affected individuals and their families.

It’s important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate recommendations.